The Neuro is participating in the Global Health campaign led by TBD Media Group in support of the World Health Organization. The documentary series aims to galvanize health care leaders, scientists, policy makers, industry, pharma and members of the general public to ensure the health of the global community.The Neuro was selected as the representative for neurological disorders and highlights the need for Open Science - transparent, borderless global science - to find effective treatments for neurological disorders.
Neurological disorders are the leading cause of disability worldwide
- Neurological disorders such as stroke, dementia, migraine, Parkinson鈥檚, epilepsy, and brain injury are collectively the leading global source of disability.
- The World Health Organization estimates that one billion people are affected by neurological disorders and that 9 million die every year from these illnesses.
- An aging population makes this an immediate and pressing challenge. By 2030, one in six people in the world will be aged 60 years or over.
The brain - final frontier
The human brain is the most complex organ, with one hundred billion nerve cells and 100 trillion connections. This complexity combined with a limited access to brain tissue, has meant that progress in understanding and treating neurological disorders has been slow.
Revolutionizing neuroscience. Transforming lives.
To meet the global challenge of neurological disorders, The Neuro has radically transformed the approach to brain science. As an Open Science institution since 2016, The Neuro has been developing open tools and infrastructure to share research data and biological samples with the global research community.
Through open collaborations and strategic partnerships with pharma and industry around the world, The Neuro is developing business models to bring open-source discoveries to the marketplace, and better capitalize on innovations in biomedicine and big data.
Neurological biobank - open and accessible to researchers worldwide
The Neuro has created the world鈥檚 first and only combined Open Science biobank and patient registry devoted to neurological diseases. It includes imaging, clinical, demographic, genetic, cellular and neuro-psychiatric data, as well as biological samples from more than 3,000 de-identified participants. The Neuro鈥檚 Open Biobank enables the global community to better investigate neurological disorders and help accelerate the development of effective treatments. All data, biospecimens and patient-derived cell lines are open to be shared with scientists and institutes worldwide.
Partnering with patients
Partnering with patients and their families in The Neuro鈥檚 Open Biobank is enabling the global research community to tackle the significant burden of brain diseases facing us all today. 鈥淎s someone living with Amyotrophic Lateral Sclerosis (ALS), I have decided to donate my patient data and biological samples to The Neuro鈥檚 Open Biobank, says Kris Noakes, patient advocate. 鈥淚t鈥檚 inspiring to be a part of something where globally people are collaborating in this manner. There is real momentum and it's wonderful to be part of something new and hopeful for patients with neurological disorders.鈥�
Brain health = Global health
鈥淭he Neuro is committed to improving the lives of patients with neurological disorders and advancing science and medicine to resolve the debilitating and destructive global burden of neurological diseases,鈥� says Dr. Guy Rouleau, Director of The Neuro. 鈥淲hen research is open, borderless, and global; and institutions share expertise and collaborate on fundamental discoveries; then new treatments for neurological diseases are within this generation鈥檚 reach, promising enormous benefits for our healthcare systems and economies.鈥�
